NEW YORK (TheStreet) -- Shares of UnitedHealth Group (UNH) are up 0.95% to $100.40 after Oppenheimer raised its price target to $108 from $94 on full year 2015 guidance delivered in a "bullish tone" at the company's annual investor day held yesterday in New York.
The Minneapolis-based healthcare company issued full year 2015 EPS guidance of $6 to $6.25, up 11% year-to-year versus prior analyst consensus of $6.13, based on revenues of $140.5 billion to 141.5 billion.
"Management appears confident that it can return to its 13% to 16% long-term EPS growth rate in 2016 and beyond. Based on the updated guidance, we are raising our FY2015 EPS estimate to $6.21 from $6.13," Oppenheimer analysts said.
Separately, TheStreet Ratings team rates UNITEDHEALTH GROUP INC as a Buy with a ratings score of A+. TheStreet Ratings Team has this to say about their recommendation:
"We rate UNITEDHEALTH GROUP INC (UNH) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow."